ARS Pharmaceuticals (SPRY) Current Assets (2020 - 2026)
ARS Pharmaceuticals (SPRY) reported Current Assets of $211.51 million for Q2 2026, down 24.8% from $281.44 million a year earlier and down 13.8% from the prior quarter.
ARS Pharmaceuticals (SPRY) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, ARS Pharmaceuticals posted Current Assets of $284.9 million, down 14.8% from FY2024.
- Current Assets has a five-year compound annual growth rate of -6.1% (FY2020 to FY2025).
- By year, Current Assets came in at $334.3 million in FY2024 (+44.3%), $231.73 million in FY2023 (-16.6%), $277.7 million in FY2022 (+357.3%) and $60.73 million in FY2021 (-84.5%).
- The Q2 2026 figure ranks as the lowest quarterly Current Assets since Q3 2024.
- Year over year, Current Assets has now declined in each of the last three quarters, with growth averaging 11.9% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q4 2022 (growth of 357.3%); the low point was Q4 2021 (a decline of 84.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $245.24 million (Q1 2026), $284.9 million (Q4 2025) and $338.86 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn | 211.51 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 211.51 Mn |
| Mar 31, 2026 | 245.24 Mn |
| Dec 31, 2025 | 284.90 Mn |
| Sep 30, 2025 | 338.86 Mn |
| Jun 30, 2025 | 281.44 Mn |
| Mar 31, 2025 | 303.86 Mn |
| Dec 31, 2024 | 334.30 Mn |
| Sep 30, 2024 | 208.79 Mn |
| Jun 30, 2024 | 220.74 Mn |
| Mar 31, 2024 | 226.24 Mn |
| Dec 31, 2023 | 231.73 Mn |
| Sep 30, 2023 | 244.47 Mn |
| Jun 30, 2023 | 255.03 Mn |
| Mar 31, 2023 | 267.35 Mn |
| Dec 31, 2022 | 277.70 Mn |
| Sep 30, 2022 | 270.80 Mn |
| Jun 30, 2022 | 263.13 Mn |
| Mar 31, 2022 | 261.33 Mn |
| Dec 31, 2021 | 60.73 Mn |
| Sep 30, 2021 | 305.36 Mn |
ARS Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=SPRY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();